A Randomized, Double-blind, Multi-center, Phase 2 Trial to Evaluate the Efficacy and Safety of Candesartan/Amlodipine Combined or Alone and Select Better Dose of CKD-330 in Patients With Essential Hypertension
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2019
Price : $35 *
At a glance
- Drugs Amlodipine/candesartan-cilexetil (Primary) ; Amlodipine; Candesartan cilexetil
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Chong Kun Dang
- 03 Mar 2017 Last checked against ClinicalTrials.gov record.
- 21 Jul 2016 Status changed from recruiting to completed.
- 02 Apr 2015 Planned End Date changed from 1 Jan 2015 to 1 Apr 2015 as reported by ClinicalTrials.gov record..